Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 2Lung Neoplasms 1Digestive System Diseases 1Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors 1Chemotherapy-induced Thrombocytopenia 1Chemotherapy Induced Thrombocytopenia 1Cancer Therapy-induced Thrombocytopenia (CTIT) 1Breast Neoplasms 1

Interventions

hetrombopag 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cancer Therapy-induced Thrombocytopenia (CTIT) × hetrombopag × Clear all
NCT07334093 2026-01-12

A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.

Sun Yat-sen University

Phase 2 Not yet recruiting
204 enrolled
Classical hematology

Cancer Therapy-induced Thrombocytopenia (CTIT)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡